Spirendolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C21H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 96789094BR, chemically known as spiro(cyclohexane-1,2-(2h)inden)-1(3h)-one, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-, (+-)- but generally known as spirendolol, which bears US NIH Compound Identifier 68857. European Medicines Agency schedules Spirendolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10623MIG. The term SPIRENDOLOL is an International Non-Proprietary Name. SPIRENDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spirendolol under HS 29221980 and SITC 51461. As of Q4 2014, SPIRENDOLOL remains the US FDA Preferred Term for this commodity. Spirendolol bears US NLM identifiers UMLS ID C0629350 and NCI Concept Code C66562. SMILES: O=C1C2(CCCCC2)CC2C1CCCC2OCC(O)CNC(C)(C)C.